Diagnosis and management of prediabetes in the continuum of hyperglycemia: when do the risks of diabetes begin? A consensus statement from the American College of Endocrinology and the American Association of Clinical Endocrinologists.
about
Obesity, Prediabetes, and Perceived Stress in Municipal WorkersRole of bile acid sequestrants in the treatment of type 2 diabetesMany Americans have pre-diabetes and should be considered for metformin therapyAntihypertensive medications: benefits of blood pressure lowering and hazards of metabolic effects.INVEST revisited: review of findings from the International Verapamil SR-Trandolapril Study.Adiponectin and pro-inflammatory cytokines are modulated in Vietnamese patients with type 2 diabetes mellitus.Anti-hyperglycemic and anti-hyperlipidemic effects of guava leaf extract.Cytokine profiling of young overweight and obese female African American adults with prediabetes.Linking Chronic Inflammation with Cardiovascular Disease: From Normal Aging to the Metabolic Syndrome.American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement--executive summary.Effect of pre-diabetes on future risk of stroke: meta-analysisOral glucose tolerance test-based calculation identifies different glucose intolerance phenotypes within the impaired fasting glucose rangeBeyond HbA1c and glucose: the role of nontraditional glycemic markers in diabetes diagnosis, prognosis, and management.Weight Loss and the Prevention and Treatment of Type 2 Diabetes Using Lifestyle Therapy, Pharmacotherapy, and Bariatric Surgery: Mechanisms of Action.Measuring the sweet smell of success in diabetes management.Liver inflammation is a risk factor for prediabetes in at-risk latinos with and without hepatitis C infection.The profile of hypertension and dyslipidemia in prediabetic subjects; results of the Isfahan Diabetes Prevention program: A large population-based study.Weight loss effect of glucagon-like peptide-1 mimetics on obese/overweight adults without diabetes: A systematic review and meta-analysis of randomized controlled trials.Valsartan combination therapy in the management of hypertension - patient perspectives and clinical utilityDo Behavioral Risk Factors for Prediabetes and Insulin Resistance Differ across the Socioeconomic Gradient? Results from a Community-Based Epidemiologic Survey.Incretin therapy--present and future.A Dietary Supplement Containing Cinnamon, Chromium and Carnosine Decreases Fasting Plasma Glucose and Increases Lean Mass in Overweight or Obese Pre-Diabetic Subjects: A Randomized, Placebo-Controlled TrialThe multi-systemic nature of diabetes mellitus: Genotype or phenotype?Advantages and pitfalls of fructosamine and glycated albumin in the diagnosis and treatment of diabetesSocial inequalities in prevalence of diagnosed and undiagnosed diabetes and impaired glucose regulation in participants in the Health Surveys for England series.Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults.Effect of concomitant administration of trospium chloride extended release on the steady-state pharmacokinetics of metformin in healthy adults.A novel use of structural equation models to examine factors associated with prediabetes among adults aged 50 years and older: National Health and Nutrition Examination Survey 2001-2006A review of the benefits of early treatment initiation with single-pill combinations of telmisartan with amlodipine or hydrochlorothiazide.Antihypertensive therapy, new-onset diabetes, and cardiovascular diseaseThe progression of cardiometabolic disease: validation of a new cardiometabolic disease staging system applicable to obesity.Prevalence of normoglycemic, prediabetic and diabetic A1c levelsIncidence of prediabetes and risk of developing cardiovascular disease in women with polycystic ovary syndromeSingle-pill combination of amlodipine and valsartan in the management of hypertension.Therapeutic interventions to reduce the risk of progression from prediabetes to type 2 diabetes mellitusConsensus on the Prevention of Type 2 Diabetes in Chinese Adults.Risk of postprandial insulin resistance: the liver/vagus rapportImproving blood pressure control rates by optimizing combination antihypertensive therapy.Prediabetes: the importance of early identification and intervention.Hypertension and lipid management in prediabetic states.
P2860
Q23917139-79816971-8F5A-4B2A-AC60-7A49F055FC37Q28236411-88F91C70-369C-4F88-B5CC-62BEC437DA72Q33556877-A86D5AEB-4045-4ED9-A726-1EF51D3C0C41Q33561456-58788945-4588-428F-8D63-FC0EC91F89C3Q33567530-956DAC53-B05F-4DB0-A391-3AFE3DBDDB76Q33633719-9902A52D-BF5A-403A-9EF6-1083600B3372Q33698706-D64A776D-3284-4AD8-AB7D-C32DDF0736DEQ33758111-964466E5-33AE-470F-830C-102480763E42Q33847586-18438708-D5A8-4DCC-9DC5-333892ACF478Q34081331-C2998626-FE64-4487-A832-39600753D129Q34296651-85077E2B-86DA-413C-AC30-475B8728DF45Q34299634-B061A59E-E50F-44AA-9112-94525B406251Q34425731-FA287298-99AC-4766-9575-EB68FD4D4ED2Q34503739-7687002B-E891-40D6-9F65-29029D587670Q34658340-59346512-87D0-4BA5-BDE9-9602B8E7002BQ34943906-FDB40B03-B010-4518-9DA1-1FCF18587117Q35098126-D08D7994-F0FB-4490-8CFA-E05D126A6191Q35209811-44A1A964-F85E-4573-AF96-E3286187DCA7Q35210583-D0DC7FFD-DA12-482A-A04E-CB58D2A6222EQ35674597-0B95294C-F2C8-4618-AF7B-33044A29FD85Q35760283-7BC184DF-032E-4D35-B77B-D4740E6A1D0BQ35788349-6D867B24-A158-4F71-B6EE-6B69C1BD0BFBQ35919282-15896893-B1E4-4275-9083-ECD35A94A7A3Q36159157-5F50F5C9-C7D7-4586-9433-ED419F7B10FAQ36559607-5AA55A56-0A92-4877-A6A2-D1DA81938E3FQ36566370-DCFDDA7C-7028-49E1-B19A-E800E3B1CF1FQ36579750-CB1C758D-1677-4603-9E8C-17F84F97CE2EQ37106601-9218C4C3-730C-4138-A480-A3EF9933173AQ37203105-2EC2C113-5C0A-4E26-86DC-609A6A9E65B3Q37250588-D7E355C0-340E-42DA-BA71-43F110A7B0D3Q37399447-06D6AB9D-46C1-45FA-8F3F-0C8530A452C7Q37417764-74C08F5C-A60E-4D1F-9474-9B37D0FBBCC1Q37471838-D1112979-065A-495B-860B-6150920A9D1CQ37552939-FF6ED461-4078-4E14-833B-8F2F86561B68Q37660219-68B56383-82E3-43E6-956B-8300DDA09A1AQ37684154-150612F0-8746-42B8-8BD3-53B7FE5653F9Q37724096-08751F67-B32F-4AE3-9068-8587275DAA38Q37768793-538E739D-C484-4F62-B54D-E55FE85A23B9Q37777010-FF0C8000-753D-4D90-B7FE-5277C02FD2D0Q37861888-470F76AD-2C32-4459-8F4B-73B53F5FDE58
P2860
Diagnosis and management of prediabetes in the continuum of hyperglycemia: when do the risks of diabetes begin? A consensus statement from the American College of Endocrinology and the American Association of Clinical Endocrinologists.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Diagnosis and management of pr ...... of Clinical Endocrinologists.
@en
Diagnosis and management of pr ...... of Clinical Endocrinologists.
@nl
type
label
Diagnosis and management of pr ...... of Clinical Endocrinologists.
@en
Diagnosis and management of pr ...... of Clinical Endocrinologists.
@nl
prefLabel
Diagnosis and management of pr ...... of Clinical Endocrinologists.
@en
Diagnosis and management of pr ...... of Clinical Endocrinologists.
@nl
P2093
P356
P1433
P1476
Diagnosis and management of pr ...... of Clinical Endocrinologists.
@en
P2093
Alan J Garber
Daniel Einhorn
Darren K McGuire
Donald A Bergman
Edward S Horton
Etie S Moghissi
George Grunberger
Harold Lebovitz
James R Gavin
Kenneth L Jones
P304
P356
10.4158/EP.14.7.933
P577
2008-10-01T00:00:00Z